Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Neuropsychiatry & TMS Group is a specialized healthcare provider focused on the intersection of psychiatry and neurology, primarily offering advanced neuromodulation treatments. The group specializes in Transcranial Magnetic Stimulation (TMS), a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve symptoms of depression and other mental health conditions. Their clinical services are designed for patients who have not seen adequate results from traditional pharmacological interventions or psychotherapy. In addition to TMS, the practice provides comprehensive neuropsychiatric evaluations and medication management for complex mood and cognitive disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Neuropsychiatry & TMS Group.